TL;DR
This study provides a comprehensive genomic and phenotypic analysis of X-linked hereditary hearing loss (HL) in the Chinese population, revealing its contribution to overall HL cases and detailing genotype-phenotype correlations. The findings are crucial for improving the diagnosis, genetic counseling, and treatment strategies for this often-understudied form of hearing impairment.
What Problem Does This Paper Address?
Hereditary hearing loss (HL) is a significant global health issue, with genetic factors accounting for a large proportion of cases. While over 150 genes are known to cause HL, X-linked inheritance is less common but presents unique challenges due to its genetic transmission patterns and the specific genes involved. Understanding the molecular basis and clinical manifestations of X-linked HL, particularly in diverse populations like China, is crucial for accurate diagnosis and effective management. Previous research has often focused on individual genes or smaller cohorts, leaving gaps in our understanding of the overall contribution of X-linked genes to HL and the intricate genotype-phenotype relationships within specific ethnic groups. This paper aims to address this by investigating a large cohort of Chinese HL patients using advanced sequencing technologies and by reviewing existing literature to consolidate knowledge on X-linked HL.
Methods
The researchers employed a multi-pronged approach combining molecular genetic techniques with clinical data analysis.
- Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS): They performed whole-exome sequencing (WES) or used a predefined panel of 227 human deafness-related genes on DNA extracted from peripheral blood of 3646 unrelated patients with HL. TGS was utilized when NGS failed to identify pathogenic variants, particularly in cases with suspected complex mutations like large deletions.
- Bioinformatics Analysis: Standard pipelines were used for variant calling, annotation, and validation, with strict filtering criteria based on allele frequencies in population databases.
- Variant Interpretation: The American College of Medical Genetics (ACMG) standards and guidelines, along with ClinGen Hearing Loss Clinical Domain Working Group expert specifications, were applied to classify the pathogenicity of identified variants.
- Literature Review: A systematic review of published literature on genes associated with X-linked HL was conducted to gather information on clinical phenotypes, audiological profiles, and genotype-phenotype correlations.
Datasets
- Patient Cohort: 3646 unrelated Chinese patients with hearing loss, recruited between 2015 and 2023.
- Literature Data: Information from NCBI PubMed and HGMD on genes associated with syndromic and non-syndromic forms of X-linked HL, up to October 2023.
Key Insights and Ideas
- X-linked HL is a significant, albeit minority, contributor to hereditary HL: While autosomal genes are more common causes, X-linked genes play a notable role, particularly in male patients.
- POU3F4 is a major driver of X-linked HL in the Chinese population: This gene accounts for a substantial portion of identified X-linked HL cases, highlighting its importance in this demographic.
- Genotype-phenotype correlations are complex but informative: Specific genes show distinct patterns of HL onset, severity, and associated malformations, which can aid in diagnosis and genetic counseling.
- Novel variants expand the known mutational landscape: The identification of 15 novel variants contributes to a more complete understanding of the genetic basis of X-linked HL.
- Sex-linked inheritance patterns are critical: Skewed X-chromosome inactivation in females can lead to variable expressivity, making diagnosis and counseling more nuanced.
Key Results
- Diagnostic Rate: 52.72% (1922/3646) of the patients received a positive molecular diagnosis for HL.
- Contribution of X-linked Genes: X-linked genes accounted for approximately 1.14% (22/1922) of the diagnosed HL cases in this cohort.
- POU3F4 Dominance: Variants in the POU3F4 gene were responsible for approximately 59% (13/22) of the X-linked HL cases.
- Novel Variants: 12 out of the 22 identified pathogenic/likely pathogenic variants were novel.
- Clinical Manifestations: X-linked HL was consistently congenital or childhood-onset. Specific genes were associated with characteristic audiological profiles (e.g., auditory neuropathy) and inner ear malformations (e.g., incomplete partition type III).
- Syndromic vs. Non-syndromic: While most identified X-linked HL cases were non-syndromic, some variants were linked to syndromic forms, underscoring the need for comprehensive clinical evaluation.
Limitations and Future Work
- Underestimation of Contribution: The study acknowledges that the contribution of X-linked genes might be underestimated due to limitations in the predefined gene panel (some known X-linked deafness genes were not included) and the potential for variants in non-coding regions or unannotated exons to be missed by current diagnostic algorithms.
- Need for Functional Assays: Seven variants of uncertain significance (VUS) were identified, requiring further functional assays to determine their pathogenicity.
- Further Exploration of COL4A6: The genotype-phenotype relationship for COL4A6 requires further exploration, as current data is primarily based on a single family.
- Novel X-linked Genes: The study suggests the possibility of novel X-linked deafness-related genes, particularly in cases with syndromic features that remain genetically undiagnosed.
- Gene Therapy Potential: For certain types of X-linked HL, such as AIFM1-related auditory neuropathy, gene therapy is suggested as a potential future treatment avenue.
- Tailored Treatment: The authors emphasize the need for individually tailored treatment modalities for X-linked NSHL, considering the specific genetic basis, degree, and type of HL.
Summary updated